MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS

被引：63

作者：

INABA, T

JURIMA, M

NAKANO, M

KALOW, W

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 36卷 / 05期

关键词：

D O I：

10.1038/clpt.1984.238

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：670 / 676

页数：7

共 22 条

[1]

ASLANIAN W, 1983, PHARMACOLOGIST, V25, P218

[2]

BOOBIS AR, 1983, MOL PHARMACOL, V23, P474

[3] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J ;

ZEKORN, C .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186

[4]

EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001

[5] THE GENETIC-CONTROL OF SPARTEINE AND DEBRISOQUINE METABOLISM IN MAN WITH NEW METHODS OF ANALYZING BIMODAL DISTRIBUTIONS [J].

EVANS, DAP ;

HARMER, D ;

DOWNHAM, DY ;

WHIBLEY, EJ ;

IDLE, JR ;

RITCHIE, J ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) :321-329

[6] A HUMAN CYTOCHROME-P-450 CHARACTERIZED BY INHIBITION STUDIES AS THE SPARTEINE DEBRISOQUINE MONOOXYGENASE [J].

INABA, T ;

NAKANO, M ;

OTTON, SV ;

MAHON, WA ;

KALOW, W .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (07) :860-862

[7] COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE [J].

INABA, T ;

VINKS, A ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :394-399

[8] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE [J].

INABA, T ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :547-549

[9]

JURIMA M, UNPUB DRUG METAB DIS

[10] THE UPJOHN-AWARD-LECTURE 1981 - THE METABOLISM OF XENOBIOTICS IN DIFFERENT POPULATIONS [J].

KALOW, W .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (01) :1-12

← 1 2 3 →